Macquarie Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-282
| Closed | -$8.42K | – | 1666 |
|
2025
Q1 | $8.42K | Buy |
+282
| New | +$8.42K | ﹤0.01% | 1654 |
|
2022
Q4 | – | Hold |
0
| – | -$5K | – | 1882 |
|
2022
Q3 | – | Sell |
-292
| Closed | -$5K | – | 2432 |
|
2022
Q2 | $5K | Hold |
292
| – | – | ﹤0.01% | 2519 |
|
2022
Q1 | $6 | Hold |
292
| – | – | ﹤0.01% | 2563 |
|
2021
Q4 | $5K | Hold |
292
| – | – | ﹤0.01% | 2570 |
|
2021
Q3 | $6K | Hold |
292
| – | – | ﹤0.01% | 2585 |
|
2021
Q2 | $7K | Hold |
292
| – | – | ﹤0.01% | 2497 |
|
2021
Q1 | $7K | Sell |
292
-139
| -32% | -$3.33K | ﹤0.01% | 2423 |
|
2020
Q4 | $9K | Hold |
431
| – | – | ﹤0.01% | 2311 |
|
2020
Q3 | $9K | Hold |
431
| – | – | ﹤0.01% | 2289 |
|
2020
Q2 | $8K | Buy |
+431
| New | +$8K | ﹤0.01% | 2307 |
|
2019
Q3 | – | Sell |
-497,011
| Closed | -$6.54M | – | 1891 |
|
2019
Q2 | $6.54M | Sell |
497,011
-1,914,707
| -79% | -$25.2M | 0.01% | 703 |
|
2019
Q1 | $36.5M | Sell |
2,411,718
-347,289
| -13% | -$5.26M | 0.06% | 327 |
|
2018
Q4 | $47.4M | Buy |
2,759,007
+221,779
| +9% | +$3.81M | 0.09% | 223 |
|
2018
Q3 | $37.4M | Sell |
2,537,228
-51,128
| -2% | -$754K | 0.06% | 329 |
|
2018
Q2 | $61.7M | Buy |
2,588,356
+233,598
| +10% | +$5.57M | 0.11% | 178 |
|
2018
Q1 | $60.2M | Buy |
2,354,758
+738,641
| +46% | +$18.9M | 0.11% | 176 |
|
2017
Q4 | $29.8M | Buy |
1,616,117
+286,138
| +22% | +$5.28M | 0.05% | 373 |
|
2017
Q3 | $14M | Buy |
1,329,979
+211,288
| +19% | +$2.22M | 0.03% | 543 |
|
2017
Q2 | $14M | Buy |
1,118,691
+302,892
| +37% | +$3.79M | 0.03% | 532 |
|
2017
Q1 | $8.21M | Buy |
815,799
+807,623
| +9,878% | +$8.12M | 0.01% | 647 |
|
2016
Q4 | $127K | Buy |
+8,176
| New | +$127K | ﹤0.01% | 1476 |
|
2016
Q2 | – | Sell |
-30,353
| Closed | -$551K | – | 1580 |
|
2016
Q1 | $551K | Buy |
+30,353
| New | +$551K | ﹤0.01% | 1220 |
|